KALVISTA PHARMACEUTICALS INC (KALV) Stock Balance Sheet
NASDAQ:KALV - Nasdaq - US4834971032 - Common Stock - Currency: USD
| MRQ (2024-10-31) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 41.58M | 31.79M | 56.20M | 30.70M | 50.60M | |||
| Marketable Securities | 94.19M | 178.61M | 93.10M | 135.50M | 198.30M | |||
| Receivables | 12.93M | 10.87M | 18.60M | 14.10M | 10.40M | |||
| Other Current Assets | 3.56M | 4.42M | 4.30M | 13.30M | 4.90M | |||
| Total Current Assets | 152.27M | 225.69M | 172.30M | 193.60M | 264.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.90M | 9.15M | 10.80M | 10.00M | 7.50M | |||
| Other Non-Current Assets | 662.00K | 567.00K | 100.00K | 200.00K | 200.00K | |||
| Total Non-Current Assets | 8.56M | 9.71M | 10.90M | 10.30M | 7.70M | |||
| TOTAL ASSETS | 160.83M | 235.40M | 183.20M | 203.90M | 272.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 16.97M | 13.70M | 10.20M | 7.90M | 7.80M | |||
| Accounts Payable | 5.20M | 9.11M | 4.80M | 3.60M | 2.00M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 22.16M | 22.81M | 15.00M | 11.60M | 9.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.67M | 6.01M | 7.10M | 7.20M | 5.00M | |||
| Total Non-Current Liabilities | 4.67M | 6.01M | 7.20M | 7.20M | 5.00M | |||
| TOTAL LIABILITIES | 26.84M | 28.82M | 22.20M | 18.80M | 14.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -552.44M | -469.73M | -343.10M | -250.20M | -167.80M | |||
| Additional Paid In Capital | 689.09M | 679.75M | 507.10M | 439.10M | 426.40M | |||
| Common Shares | 43.00K | 42.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -2.70M | -3.49M | -3.10M | -3.90M | -1.40M | |||
| Shares Outstanding | 43.27M | 42.52M | 34.20M | 24.60M | 24.40M | |||
| Tangible Book Value per Share | 3.10 | 4.86 | 4.71 | 7.52 | 10.54 | |||
| Total Shareholders' Equity | 133.99M | 206.58M | 161.00M | 185.10M | 257.20M | |||
| TOTAL LIABILITIES AND EQUITY | 160.83M | 235.40M | 183.20M | 203.90M | 272.00M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 6.87 | 9.90 | 11.49 | 16.69 | 26.97 | |||
| Return On Assets (ROA) | -97.24% | -53.80% | -50.72% | -40.38% | -17.00% | |||
| Return On Equity (ROE) | -116.71% | -61.30% | -57.71% | -44.48% | -17.98% | |||
All data in USD , ROIC based on taxRate of 0.21